Compounds as pharmaceutical agents
US7405299B2 · kind B2 · utility
9Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2003 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Oct 19, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.